Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/23189
Title: Desacyl ghrelin prevents doxorubicin-induced myocardial fibrosis and apoptosis via the GHSR-independent pathway
Authors: Pei, XM
Yung, BY 
Yip, SP 
Ying, M 
Benzie, IF 
Siu, PM 
Keywords: Adriamycin
Apoptosis
Cardiomyopathy
Chemotherapy
Fibrosis
Growth hormone secretagogue receptor
Unacylated ghrelin
Issue Date: 2014
Publisher: American Physiological Society
Source: American journal of physiology. Endocrinology and metabolism, 2014, v. 306, no. 3, p. E311-E323 How to cite?
Journal: American journal of physiology. Endocrinology and metabolism 
Abstract: Doxorubicin is an effective chemotherapeutic agent used to treat malignancies, but it causes cardiomyopathy. Preliminary evidence suggests that desacyl ghrelin might have protective effects on doxorubicin cardiotoxicity. This study examined the cellular effects of desacyl ghrelin on myocardial fibrosis and apoptosis in a doxorubicin cardiomyopathy experimental model. Adult C57BL/6 mice received an intraperitoneal injection of doxorubicin to induce cardiomyopathy, followed by 4-day treatment of saline (control) or desacyl ghrelin with or without [D-Lys3]-GHRP-6 (a growth hormone secretagogue receptor or GHSR1a antagonist). Ventricular structural and functional parameters were evaluated by transthoracic echocardiography. Molecular and cellular measurements were performed in ventricular muscle to examine myocardial fibrosis and apoptosis. Cardiac dysfunction was induced by doxorubicin, as indicated by significant decreases in ventricular fractional shortening and ejection fraction. This doxorubicin-induced cardiac dysfunction was prevented by the treatment of desacyl ghrelin no matter with or without the presence of [D-Lys3]-GHRP-6. Doxorubicin induced fibrosis (accumulated collagen deposition and increased CTGF), activated apoptosis (increased TUNEL index, apoptotic DNA fragmentation, and caspase-3 activity and decreased Bcl-2/Bax ratio), and suppressed phosphorylation status of prosurvival signals (ERK1/2 and Akt) in ventricular muscles. All these molecular and cellular alterations induced by doxorubicin were not found in the animals treated with desacyl ghrelin. Notably, the changes in the major markers of apoptosis, fibrosis, and Akt phosphorylation were found to be similar in the animals following the treatment of desacyl ghrelin with and without GHSR antagonist [D-Lys3]-GHRP-6. These findings demonstrate clearly that desacyl ghrelin protects the cardiomyocytes against the doxorubicin-induced cardiomyopathy by preventing the activation of cardiac fibrosis and apoptosis, and the effects are probably mediated through GHSR-independent mechanism.
URI: http://hdl.handle.net/10397/23189
ISSN: 0193-1849
EISSN: 1522-1555
DOI: 10.1152/ajpendo.00123.2013
Appears in Collections:Journal/Magazine Article

Access
View full-text via PolyU eLinks SFX Query
Show full item record

SCOPUSTM   
Citations

22
Last Week
0
Last month
0
Citations as of Nov 18, 2017

WEB OF SCIENCETM
Citations

22
Last Week
0
Last month
1
Citations as of Nov 15, 2017

Page view(s)

65
Last Week
0
Last month
Checked on Nov 19, 2017

Google ScholarTM

Check

Altmetric



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.